Mycophenolate in idiopathic inflammatory myositis: outcome data of a large South Asian cohort.

Mycophenolate is an effective treatment option in IIM patients with and without co-existing ILD. Presence of Gottron's rash and absence of pericardial effusion were found to be predictors of favourable clinical outcome in this largest single-centre study.